Exane Derivatives’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $87.2K | Hold |
8,683
| – | – | 0.05% | 274 |
|
|
2022
Q1 | $107K | Buy |
8,683
+1,182
| +16% | +$14.6K | 0.03% | 464 |
|
|
2021
Q4 | $172K | Sell |
7,501
-6,828
| -48% | -$156K | 0.04% | 361 |
|
|
2021
Q3 | $317K | Buy |
14,329
+1,185
| +9% | +$26.2K | 0.08% | 265 |
|
|
2021
Q2 | $157K | Buy |
13,144
+4,404
| +50% | +$52.5K | 0.04% | 452 |
|
|
2021
Q1 | $113K | Sell |
8,740
-1,388
| -14% | -$18K | 0.03% | 396 |
|
|
2020
Q4 | $140K | Buy |
10,128
+5,028
| +99% | +$69.5K | 0.04% | 341 |
|
|
2020
Q3 | $75.1K | Buy |
5,100
+1,700
| +50% | +$25K | 0.02% | 324 |
|
|
2020
Q2 | $55.2K | Buy |
+3,400
| New | +$55.2K | 0.01% | 327 |
|